All about Canadian investments. Learn the ins and outs and get the latest news.
Latest News
The best student credit cards in Canada for 2023 Oct 12th
Credit Cards
The best student credit cards in Canada for 2023
Searching for the perfect credit card? In under 60 seconds, CardFinder narrows down your top matches without impacting your credit score, no SIN required.
Find my perfect card*
.... More »
The best GIC rates in Canada for 2025 + MORE Jul 14th
GIC comparison tool
Find the best and most up-to-date GIC rates in Canada using the comparison tool below. Plus, use the filters to assess your estimated rate of return based on the size of your balance.
Why trust us
MoneySense is an award-winning magazine, helping Canadians navigate m.... More »
5 smart strategies for renewing your mortgage + MORE Mar 24th
Owning a home has plenty of benefits, but it’s not without challenges. Over one million mortgages in Canada are set to renew in the next few years, and many home owners will be faced with higher interest rates. If you’re in this situation, you may feel squeezed in two ways: a higher interest rat.... More »
Near retirement with no defined benefit pension? Here’s what you need to know Oct 21st
If you’re a typical reader of this column, I’m guessing retirement is on the near-term horizon for you, or already arrived in the form of “semi-retirement.” And if you’ve diligently saved in registered and taxable plans all these decades but lack an employer-sponsored defined benefit (DB) .... More »
Having a financial plan more than doubles your retirement confidence—here’s why so many Canadians are skipping it + MORE Oct 9th
A new KPMG survey reveals that eight in 10 Canadians with a professional financial plan feel confident they can retire at their desired age. Among those without one? Just 36%.
That’s a massive gap—and it’s widening at a time when more Canadians are rethinking their financial strateg.... More »
Biotech stocks: are they worth a shot?
– moneysense.ca
There’s a hot new investment on the market that wouldn’t have been on many people’s radars only a few weeks ago: COVD-19 vaccine-makers. Since March 16, when quarantine began in earnest, Moderna, a Cambridge company that’s making a novel coronavirus vaccine, has climbed by 244%. Novavax, a Rockville, Maryland-based vaccine development company, has seen its shares skyrocket by 644% since mid-March. Shares of Vaxart, a little-known San Francisco-based company that’s developing an oral COVID-19 vaccine, have climbed by 736% since January. Those kinds of numbers would surely look good in any pandemic-hit portfolio right about now.
As exciting as the vaccine businesses may be, there is a better way to spend your money. Go to Vegas when the border reopens and put everything on black. While you might come back empty-handed, at least that loss comes with good food and a show.
You see, despite some huge gains over the last few weeks, and interest from investors big and small, betting on vaccines is no different than playing roulette…
As exciting as the vaccine businesses may be, there is a better way to spend your money. Go to Vegas when the border reopens and put everything on black. While you might come back empty-handed, at least that loss comes with good food and a show.
You see, despite some huge gains over the last few weeks, and interest from investors big and small, betting on vaccines is no different than playing roulette…
